Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Children With Severe AD Catch Up on Growth With DupilumabEffective treatment with dupilumab may allow younger children with severe atopic dermatitis and short stature to catch up
on their growth, potentially offering lifelong benefits, according to the results of a study of children aged 6-11 years.
Medscape Medical News, Oct 16, 2024
Topical JAK inhibitor Provides Sustained Control of HSRuxolitinib cream applied on an as-needed basis provided sustained clearance of hidradenitis suppurativa nodules during the
open-label extension of a phase 2 trial.
Medscape Medical News, Oct 03, 2024
Facial Melasma Improves With New CosmeceuticalA new serum containing 2-mercaptonicotinoyl glycine as its main ingredient was at least as good as cysteamine 5% cream in
treating facial melasma in a randomized study.
